Literature DB >> 6703263

Effect of platelet activating factor on the human nasal mucosa.

U Pipkorn, G Karlsson, B Bake.   

Abstract

In order to determine the effect of PAF-acether on the vascular bed in the human nose, 11 healthy volunteers were studied. Rhinomanometry was performed to determine the effect on the capacitance vessels, and the 133Xe wash-out method enabled determination of the mucosal blood flow, regulated mainly by the resistance vessels. These measurements were made before and after topical administration of PAF-acether in three different doses; 0.26 micrograms, 2.6 micrograms and 26 micrograms per nostril. The results indicate that PAF-acether induces a dose-dependent vasoconstriction of the capacitance vessels and a reduction in mucosal blood flow. That PAF-acether should be a principal mediator in the allergic reaction in the human nose is not supported by these findings.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6703263     DOI: 10.1111/j.1398-9995.1984.tb01946.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  5 in total

1.  Eosinophil chemotactic activity of topical PAF on the human nasal mucosa.

Authors:  H Klementsson; M Andersson
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Nasal provocation.

Authors:  U Pipkorn
Journal:  Clin Rev Allergy       Date:  1988

3.  Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.

Authors:  A J Wardlaw; R Moqbel; O Cromwell; A B Kay
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

4.  Effect of disodium chromoglycate on changes in nasal airway resistance induced by platelet activating factor.

Authors:  G Karlsson; U Pipkorn
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  The effect of platelet activating factor on nasal hypersensitivity.

Authors:  M Andersson; U Pipkorn
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.